Arkolith/Insider Trading/RNA/Form 4

Hughes Steven George

Chief Medical OfficerAvidity Biosciences, Inc. (RNA) · full profile →Form 4 · filed Aug 15, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$72K
Net Open-Market Flow
-$72K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 13, 2025Option exercise(M)2K$6.57$10K40K
Aug 13, 2025Sell(S)2K$46.66$72K39K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 13, 2025Option exercise(M)2K—$051K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001599901-25-000159) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML